Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow Reinvestment Rate
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow Reinvestment Rate of 0.01x as of December 2025, reinvesting AU$149.47K (capex AU$149.47K ) from operating cash flow of AU$12.52 Million. Check CUV cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Clinuvel Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Clinuvel Pharmaceuticals Ltd across 9 annual periods. Explore Clinuvel Pharmaceuticals Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Clinuvel Pharmaceuticals Ltd. For live market cap and broader valuation context, see Clinuvel Pharmaceuticals Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.17x | AU$48.01 Million | AU$41.10 Million | AU$298.57K | ▲ +25.1% |
| 2024 | 0.93x | AU$34.61 Million | AU$37.05 Million | AU$5.58 Million | ▲ +1577.7% |
| 2023 | 0.06x | AU$2.06 Million | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.02x | AU$868.88K | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.09x | AU$1.71 Million | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.13x | AU$1.78 Million | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.03x | AU$515.23K | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$150.25K | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$134.96K | AU$9.92 Million | AU$67.48K | — |